ACVR2B and cancer: Investigations have been performed on the clinical potentials of the ACVR2B-signaling inhibitors in relieving multi-organ co-morbidities and cachexia-accompanying cancers, side effects of chemotherapy, and muscle damage caused by other diseases, such as ischemic heart failure.